Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study
PaperCitations, authors & open-access status
Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 1,272 citations, 2015 year and closed oa status.
1,272
Citations
2015
Year
closed
OA Status